Table 4 Mortality and health service utilisation by patient clusters in each age stratum. Clusters are ordered by the highest to the lowest mortality. The non-multimorbid cluster contains patients with zero or only one long-term condition. The number of GP consultations, hospitalisations and repeat prescriptions (by counting the number of unique BNF codes that were in repeated prescriptions at least four times) are measured in 1 year after January 2012. Both mean and median are reported because they highlight different aspects of skewed distributions, especially in relation to hospitalisations and prescriptions
Three key conditions (prevalence) | 2-year mortality (%) | 5-year mortality (%) | No. of GP contacts in a year (mean, median [Q1–Q3]) | No. of hospitalisations in a year (mean, median [Q1–Q3]) | No. of unique medicine on repeat prescriptions in a year (mean, median [Q1–Q3]) | |
|---|---|---|---|---|---|---|
Lead condition (%) | Subsidiary conditions (%) | |||||
Age 18–44 years | ||||||
PSM (75%) | Alcohol (42%), depression (24%) | 1.8 | 3.9 | 10.7, 7 [1–16] | 0.4, 0 [0–0] | 1.3, 0 [0–2] |
Pain (36%) | Hearing loss (30%), hypertension (23%) | 1.0 | 2.7 | 11.9, 9 [3–17] | 0.6, 0 [0–0] | 2.5, 1 [0–4] |
Depression (100%) | Anxiety (41%), pain (31%) | 0.9 | 1.8 | 14.5, 12 [5–20] | 0.4, 0 [0–0] | 2.4, 2 [0–3] |
Asthma (100%) | IBS (26%), depression (20%) | 0.2 | 0.6 | 11.3, 9 [4–16] | 0.4, 0 [0–0] | 1.9, 1 [0–3] |
IBS (100%) | Depression (29%), hearing loss (21%) | 0.2 | 0.4 | 10.6, 8 [3–15] | 0.4, 0 [0–0] | 1.2, 0 [0–2] |
Non-multimorbid | 0.1 | 0.2 | 3.7, 1 [0–5] | 0.2, 0 [0–0] | 0.2, 0 [0–0] | |
Age 45–64 years | ||||||
Alcohol (62%) | PSM (42%), pain (28%) | 4.5 | 12.5 | 10.7, 8 [2–16] | 0.5, 0 [0–1] | 2.4, 1 [0–4] |
Depression (93%) | Pain (53%), anxiety (31%) | 2.4 | 5.8 | 16.7, 14 [7–23] | 0.6, 0 [0–1] | 5.1, 4 [2–7] |
Hypertension (76%) | Diabetes (37%), pain (25%) | 1.6 | 4.4 | 11.5, 9 [4–16] | 0.5, 0 [0–0] | 4.1, 4 [1–6] |
IBS (40%) | Hearing loss (29%), pain (28%) | 1.3 | 3.0 | 10.5, 8 [3–15] | 0.5, 0 [0–0] | 2.0, 1 [0–3] |
Asthma (100%) | Pain (24%), COPD (16%) | 1.0 | 2.7 | 12.6, 10 [5–17] | 0.4, 0 [0–0] | 3.4, 3 [1–5] |
Non-multimorbid | 0.4 | 1.3 | 4.4, 2 [0–6] | 0.2, 0 [0–0] | 0.5, 0 [0–0] | |
Age 65–84 years | ||||||
Pain (81%) | CHD (53%), depression (45%) | 16.2 | 39.2 | 26.3, 23 [14–35] | 1.6, 1 [0–2] | 10.7, 11 [8–14] |
CHD (54%) | Diabetes (32%), atrial fibrillation (29%) | 11.3 | 28.8 | 16.8, 14 [6–24] | 1.1, 0 [0–1] | 5.9, 6 [3–8] |
COPD (57%) | Asthma (49%), pain (33%) | 9.2 | 25.5 | 15.7, 13 [6–22] | 0.8, 0 [0–1] | 5.5, 5 [2–8] |
Depression (56%) | Pain (56%), anxiety (23%) | 8.4 | 20.9 | 17.3, 14 [8–23] | 0.8, 0 [0–1] | 5.9, 6 [3–8] |
Hypertension (100%) | Diabetes (31%), pain (27%) | 4.7 | 13.2 | 12.4, 10 [4–17] | 0.6, 0 [0–1] | 4.5, 4 [2–7] |
Hearing loss (40%) | Prostate disorder (21%), IBS (3%) | 4.4 | 11.1 | 13.2, 11 [5–19] | 0.7, 0 [0–1] | 3.3, 3 [1–5] |
Non-multimorbid | 1.9 | 6.6 | 6.4, 4 [0–9] | 0.3, 0 [0–0] | 1.2, 0 [0–2] | |
Age 85+ years | ||||||
CHD (61%) | Atrial fibrillation (53%), heart failure (49%) | 37.7 | 70.8 | 21.9, 18 [9–31] | 1.5, 1 [0–2] | 8.0, 8 [5–11] |
Pain (64%) | Depression (41%), constipation (24%) | 31.1 | 62.9 | 17.3, 15 [7–24] | 0.8, 0 [0–1] | 6.7, 7 [4–10] |
Asthma (48%) | COPD (48%), pain (44%) | 28.0 | 56.5 | 19.6, 17 [9–27] | 1.1, 0 [0–2] | 6.9, 7 [4–10] |
Hypertension (72%) | Hearing loss (39%), diabetes (18%) | 20.9 | 49.5 | 13.0, 10 [2–19] | 0.8, 0 [0–1] | 4.1, 4 [0–6] |
Non-multimorbid | – | 13.4 | 36.0 | 6.7, 3 [0–10] | 0.4, 0 [0–0] | 1.3, 0 [0–2] |